The ATTAIN program encompasses multiple Phase 3 trials in obesity (ATTAIN-1, ATTAIN-2, ATTAIN-3, ATTAIN-MAINTAIN), while the ACHIEVE program covers type 2 diabetes indications (ACHIEVE-1 through ACHIEVE-5, plus regional studies)
Nausea typically lessens significantly by weeks 2-3 as your body adjusts to the medication
By Train/Tube: The nearest station is Five Ways Station, approximately 0.5 miles away (10 min walk)
Phentermine (injection form, less common) appetite suppressant, short-term use only Of these, semaglutide and tirzepatide are the clear frontrunners in 2025
Getting started is straightforward: schedule a telehealth visit, discuss your medical history and lipid panel results, and if appropriate, begin treatment immediately